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trophils  could  switch  cell  fates,  or 
possibly even revert to the less-dif-
ferentiated CMP state.
The  work  of  Laslo  et  al.  (2006) 
represents  a  significant  advance 
in  understanding  the  molecular 
mechanisms that regulate CMP dif-






context  of  hematopoiesis  (Cantor 
and Orkin, 2001),  it  is also unlikely 
to  be  the  last.  Irreversible  resolu-
tion  of  lineage  priming  appears  to 
be a common feature of blood cell 
differentiation and may in fact be a 
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Limitations on a differentiated cell’s pluripotency can be erased by nuclear transfer or by 
fusion with embryonic stem cells, but attempts to recapitulate this process of nuclear repro-
gramming by molecular means have failed. In this issue of Cell, Takahashi and Yamanaka 
(2006) take a rational approach to identifying a suite of embryonic transcription factors 
whose overexpression restores pluripotency to adult somatic cells.The  phenomenon  of  nuclear  repro-
gramming was first demonstrated in 
the  context  of  somatic  cell  nuclear 
transfer  experiments.  These  experi-
ments showed that the developmen-
tal  state of  a  nucleus  from an adult 
somatic  cell  can  be  reprogrammed 
upon  its  transfer  into an unfertilized 
oocyte.  Such  a  strategy  can  result 
in the generation of cloned embryos 
with  the  potential  to  develop  into 
another entire animal, such as Dolly 
the  sheep  (Wilmut  et  al.,  1997). 
Although cloning experiments were, 
and still are, inefficient, they provide 
definitive  proof  that  pluripotency 652  Cell 126, August 25, 2006 ©2006 Elscan be  restored  to  the nucleus of a 
terminally differentiated cell. Subse-
quently,  cell  fusion  experiments  in 
which  adult  somatic  cells  are  fused 
with  mouse  embryonic  germ  cells, 
mouse  embryonic  stem  (ES)  cells, 
or  human ES cells  have shown  that 
these  pluripotent  cells  also  harbor 
reprogramming  activities  (Cowan  et 
al.,  2005;  Tada  et  al.,  2001).  These 
findings  demonstrate  the  biological 
reality of nuclear reprogramming, yet 
the  nature  and  identity  of  the  mol-
ecules  in  an  oocyte  or  pluripotent 
cell  that constitute this activity have 
remained elusive.evier Inc.In this issue of Cell, Takahashi and 
Yamanaka  (2006)  take  a  significant 
step  toward delineating  the minimal 
set of  factors required to confer  the 
developmental  potential  of  an  ES 
cell  onto  a  terminally  differentiated 
somatic  cell.  Leveraging  the  knowl-
edge  that ES cells have  reprogram-
ming  capabilities,  the  authors  rea-
soned that forcing the expression of 
ES  cell-specific  genes,  particularly 
transcription  factors,  in  somatic 
cells might induce them to take on a 
more  embryonic  character.  In  order 
to assay  for  reprogramming, mouse 
fibroblasts  were  generated  that 
harbored  a  drug  selection  cassette 
under the control of a promoter active 
only in ES cells (Fbx15). Both mouse 
embryonic  fibroblasts  and  fibrob-
lasts  from the  tail  tips of adult mice 
(MEFs and TTFs,  respectively) were 
subjected  to  this  reprogramming 
strategy.  The  authors  deduced  that 
nuclear  reprogramming  had  taken 
place  if  these fibroblasts expressed 
β-galactosidase activity and became 
resistant  to  high  concentrations  of 
neomycin (Figure 1A).
To  induce  reprogramming,  the 
authors  cotransduced  the  target 
fibroblasts  with  retroviral  vectors, 
each carrying a unique cDNA encod-
ing  a  candidate  reprogramming 









and  some  more  commonly  associ-
ated  with  transformation  that  have 
also been  implicated  in  the mainte-
nance of ES cell pluripotency (c-Myc, 
Eras,  and Klf4).  The  transduction of 
any  one  of  these  factors  alone was 
insufficient  to  induce  expression  of 
the embryonic reporter. Remarkably, 
however,  simultaneous  transduction 




phology  and  growth  characteristics 
of ES cells.
By  cleverly  repeating  this  experi-
ment with pools of  retroviruses  that 
lacked  just  one of  the 24 candidate 
genes,  Takahashi  and  Yamanaka 
(2006)  identified a set of ten cDNAs 
that  when  introduced  together  into 
their  Fbx15:β-geo  reporter  fibrob-
lasts  could  induce  the  formation 
of  ES  cell-like  colonies.  The  result-
ing  ES-like  cells  were  termed  “iPS-
MEF10”  cells,  short  for  induced 
pluripotent  stem  cells  from  MEFs 
by  10  factors.  By  reiterating  this 
approach, the authors ultimately nar-
rowed the pool of cDNAs required to 




dase-positive cells are  identified  (Takahashi and Yamanaka, 2006). These cells, called  iPS  (in-
duced pluripotent stem cells), have many of the characteristics of embryonic stem cells. 



















iments,  the  introduction  of  Oct3/4, 
c-Myc,  and  Klf4  proved  to  be  the 
only combination of three genes that 
could give rise to rapidly proliferating, 
drug-resistant  cell  lines.  However, 
further  experiments  demonstrated 
that  these  iPS-MEF3  cells  differed 
substantially from their counterparts 
that  also  expressed  Sox2.  Impor-
tantly, when  tail-tip  fibroblasts  from 
adult  mice  were  transduced  with 
pools  of  viruses  encoding  the  four 
cDNAs,  the  authors  were  able  to 
isolate  ES  cell-like  “iPS-TTF”  cells, 
indicating  that  adult  somatic  cells 
could also be reprogrammed by this 
methodology.
These  observations  raise  the 
question:  Do  the  reprogrammed 
iPS cells have the salient features of 
authentic ES cells? IPS-MEF3, 4, and 
10  cells  all  possessed  the  immortal 
growth  characteristics  of  genuine, 
self-renewing  ES  cells.  These  iPS 
cells were also able  to  form embry-
oid bodies  in vitro and  teratomas  in 
vivo. In these assays iPS-MEF10 and 
iPS-MEF4  cells,  but  not  iPS-MEF3 
cells, were able to differentiate into a 
variety of distinct cell types, demon-
strating  their  developmental  poten-
tial. Most remarkably, when iPS-TTF 
cells were injected into mouse blas-










not  identical  to  ES  cells.  First,  the 
absence  of  any  contribution  from 
iPS-derived  cells  to  postnatal  ani-




rare  iPS  clones  showed  expression 
patterns of known ES-specific genes 
that were very  similar  to controls,  a 
substantial degree of clone-to-clone 654  Cell 126, August 25, 2006 ©2006 Elvariation was observed. Some clones 
failed  to  reactivate  a  number  of  the 





more  closely  to  the  ES  cells  than 
they did to their parental fibroblasts, 
they  still  possessed  a  distinct  gene 
expression  signature.  Third,  DNA 
methylation  of  the Oct3/4  promoter 




diate  between  their  somatic  origins 
and  fully  reprogrammed  ES  cells 
(Figure 1B, bottom). In summary, the 
nuclear  reprogramming  observed 
by  introduction  of  transcription  fac-
tors into somatic cells is substantial, 
but it differs from the more complete 
reprogramming  that  is  observed 
after transfer of nuclei  from somatic 
cells  into  oocytes  (Figure  1B,  top) 
or  after  fusion of  somatic  cells with 
ES cells (Figure 1B, middle). Clearly, 
an  important  question  remains:  Are 
these  cells  in  fact  trapped  in  an 
intermediate  state  between  somatic 
cells and ES cells, or are they actu-
ally some other pluripotent cell type, 
such  as  embryonic  carcinoma  (EC) 
cells?
Takahashi and Yamanaka’s (2006) 
observations  raise  other  intriguing 
questions. If expression of the virally 
encoded  transgenes  is  constitu-
tive, as the authors suggest, how do 
the  iPS  cells  begin  to  undergo  dif-
ferentiation?  Could  introduction  of 
additional cDNAs result  in cells  that 
would be more fully reprogrammed? 
Would more  prolonged  culture  lead 






interest  is  the stability of  the  repro-
grammed  state.  If  reactivation  of 
embryonic  genes  and  epigenetic 
reprogramming  is  incomplete,  can 
the  iPS  cells  maintain  their  undif-
ferentiated  state  without  continued 
expression  of  the  viral  transgenes? sevier Inc.This question is particularly pressing 
given  the  incomplete  demethylation 
of  the Oct3/4 promoter and  the  low 
level of transcription originating from 
the  endogenous  alleles  of  Oct3/4 
and Sox2.
Another  point  of  curiosity  is  how 




the  infrequent  appearance  of  these 
cells  is  caused  by  low  cotransduc-
tion efficiency. It seems plausible, as 
the  authors  suggest,  that  there  is  a 
small  range of  expression  levels  for 
each of  the  factors  that can  lead  to 
reprogramming and only rarely does 
a  cell  receive  the  proper  retroviral 
dosage.  Another  possibility  is  that 
the  cells  being  successfully  repro-
grammed  are  actually  progenitors 
rather  than  the  terminally  differenti-
ated  fibroblasts  that  constitute  the 
majority of cells in the cultures.
Nevertheless,  the  surprising  fact 
that  any  pluripotent  cells  could  be 
recovered by introducing embryonic 
transcription  factors  into  fully  dif-
ferentiated  somatic  cells  provides 
an  additional  perspective  on  the 
regulation  of  a  cell’s  developmental 
identity.  Just  as  overexpression  of 
MyoD  alone  leads  to  the  upregula-
tion of muscle gene products and the 
induction  of  muscle  characteristics 
in fibroblasts (Weintraub et al., 1989), 
Takahashi  and  Yamanaka’s  (2006) 
work  lends  further  credence  to  the 
notion  that  perturbing  a  transcrip-
tional network at a limited number of 
nodes can force it from one metast-







genes  c-Myc  and  Klf4?  Although 
c-Myc  is  known  to  increase  the 
expression  of  a  number  of  genes 
important  for  proliferation  and  self-
renewal  (telomerase  perhaps  being 
one  of  the  most  important)  (Cart-
wright et al., 2005), it may also have 
functions  beyond  direct  transcrip-
tional  regulation.  The  large  number 
of  predicted  c-Myc  binding  sites  in 
the genome and its association with 
histone acetyltransferase complexes 
prompted  the  authors  to  speculate 
that  c-Myc  may  induce  global  his-
tone  acetylation  (Fernandez  et  al., 
2003), perhaps allowing Oct3/4 and 
Sox2  to  bind  to  otherwise  inacces-
sible sites. Unlike c-Myc, the role of 
Klf4 in reprogramming is more likely 
to  be  strictly  one  of  transcriptional 
control.  Its  key  contribution  to  this 
process is probably to downregulate 
the transcription of p53 (Rowland et 
al.,  2005),  which  is  known  to  regu-
late expression of Nanog  (Lin et al., 
2005). Repression of p53 also inhib-




between  them  could  be  crucial  for 
successful reprogramming.
Not  only  does  the work  of  Taka-
hashi  and  Yamanaka  (2006)  lend 
important  insight  into  the  molecu-
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protein aggregation, such as Ppluripotency,  it  represents a signifi-
cant step toward a rational approach 
for  generating  patient-specific  ES 
cell  lines  that  could be  used  either 
as  a  source  of  autologous  tissue 
for  transplantation  or  for  modeling 
different  diseases.  This  method  is 
encumbered  by  neither  the  logis-
tical  constraints  nor  the  societal 
concerns presented by somatic cell 
nuclear  transfer.  However,  practi-
cal application of this approach still 
requires  answering  questions  con-
cerning  the  incomplete  nature  of 
the  reprogramming  observed,  the 
constitutive expression of the trans-
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